O2h Ventures — 2026 Investments

1 investments dated 2026 · listed companies and verified rows first · show all

Hawkhill Therapeuticshawkhilltherapeutics.comApr 2026

BiotechDundee, Scotland

Timothy Jason Sparey(Executive Officer)Antoine Boulanger(Executive Officer)Francisca Peixoto(Executive Officer)Christopher Andrew Woodland(Executive Officer, Director)

BoardMary Canning(Executive Officer)

Co-investorsEpidarex Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.